Heparanase: Breaking down barriers in tumors (original) (raw)

Nature Medicine volume 5, pages 735–736 (1999)Cite this article

Abstract

Cloning and functional characterization of the long sought-after heparanase opens a new chapter in the understanding and potential manipulation of metastasis and inflammatory processes (pages 793–809).

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: Possible roles of heparanase in inflammation and tumor invasion.

References

  1. Vlodavsky, I. et al. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nature Med. 5, 793–802 (1999).
    Article CAS Google Scholar
  2. Hulett, M.D. et al. Cloning of mammalian heparanase: an essential enzyme involved in tumor invasion and metastasis. Nature Med. 5, 803–809 (1999).
    Article CAS Google Scholar
  3. Chambers, A.F. & Matrisian, L.M. Changing views of the role of matrix metalloproteinases in metastasis J. Natl. Cancer Inst. 89, 1260–1270 (1997).
    Article CAS Google Scholar
  4. Arribas, J. et al. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloproteinase inhibitors. J. Biol. Chem. 271, 11376–11382 (1996).
    Article CAS Google Scholar
  5. Nissen, N., Shankar, R., Gamelli, R., Singh, A. & DiPietro, L. Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. Biochem. J. 338, 637–642 (1999).
    Article CAS Google Scholar
  6. Freeman, C. & Parish, C.R. A rapid quantitative assay for the detection of mammalian heparanase activity. Biochem. J. 325, 229–237 (1997).
    Article CAS Google Scholar
  7. Bame, K., Hassall, A., Sanderson, C., Venkatesan, I. & Sun, C. Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases. Biochem. J. 336, 191–200 (1998).
    Article CAS Google Scholar
  8. Toyoshima, M., Dong, J., Kukula, A., Watanabe, T. & Nakajima, M. Purification and expression of human heparanase associated with tumor metastasis. Proc. Am. Assoc. Cancer Res. 40, 452 abstract 2988 (1999).
    Google Scholar
  9. Kosir, M.A., Wang, W., Zukowski, K.L., Tromp, G. & Barber, J. Degradation of basement membrane by prostate tumor heparanase. J. Surg. Res. 81, 42–47 (1999).
    Article CAS Google Scholar
  10. Vlodavsky, I. et al. Extracellular matrix-resident factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Met. Rev. 9, 201–226 (1990).
    Article Google Scholar
  11. Schwartz, L.C. et al. Relationship between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes. Cancer Lett. 51, 187–192 (1990).
    Article Google Scholar
  12. Mollinedo, F. et al. Major co-localization of the extracellular degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochem. J. 327, 917–923 (1997).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Tumor Biology and Metastasis, Section of Cancer Therapeutics, Institute of Cancer Research, Cotswold Road, Sutton, SM2 5NG, Surrey, UK
    Suzanne A. Eccles

Authors

  1. Suzanne A. Eccles
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Eccles, S. Heparanase: Breaking down barriers in tumors.Nat Med 5, 735–736 (1999). https://doi.org/10.1038/10455

Download citation

This article is cited by